Comparison 17. Honey products versus alternatives.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Complete healing at 12 weeks | 2 | 476 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.15 [0.96, 1.38] |
2 Incidence of ulcer infection during the 12‐week trial period | 2 | 476 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.71 [0.49, 1.04] |
3 Participants with MRSA eradication at 4 weeks | 1 | 16 | Risk Ratio (M‐H, Fixed, 95% CI) | 4.2 [0.67, 26.30] |
4 Participants reporting at least 1 adverse event | 1 | 368 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.28 [1.05, 1.56] |